MedPath

Image Quality: Ultra-Low Dose Scanner Versus Standard Dose Conventional Scanner for Thoraco-abdominopelvic Scans

Not Applicable
Completed
Conditions
Imaging, Diagnostic
Lung Diseases
Bone Diseases
Abdomen Disease
Pelvis Disease
Interventions
Radiation: Ultra-Low-Dose thoraco-abdominopelvic scan
Registration Number
NCT05840003
Lead Sponsor
Centre Hospitalier Universitaire de Nīmes
Brief Summary

The new image reconstruction algorithm (Precise Image, Philips Healthcare) has a strong potential to maintain sufficient image quality suitable for diagnosis with ultra-low dose (ULD) chest and abdomen-pelvis scans.

The hypothesis is that the images obtained with the Precise Image algorithm for ULD acquisitions are of sufficient and suitable quality for the diagnosis of certain lung, abdominal-pelvic and bone lesions.

Detailed Description

Recently a new image reconstruction algorithm based on Deep-learning has been developed (Precise Image, Philips Healthcare). Initial studies on phantoms have shown that this algorithm improves image quality and reduces patient dose compared to the iDose4 iterative reconstruction algorithm. Feasibility studies have validated the image quality for low-dose levels (LD). However, this algorithm has a strong potential to maintain sufficient image quality suitable for diagnosis with ultra-low dose (ULD) chest and abdomen-pelvis scans.

The hypothesis is that the images obtained with the Precise Image algorithm for ULD acquisitions are of sufficient and suitable quality for the diagnosis of certain lung, abdominal-pelvic and bone lesions.

The purpose of this study is to evaluate the concordance of the global quality of thoraco-abdominopelvic images of a ULD scan acquisition compared to a standard dose CT acquisition and measure the global agreement of the global quality of the images with a 4-point Likert scale.

The ULD acquisition will allow a significant reduction in the X-ray dose delivered to patients compared to a standard dose conventional scanner. This reduction is estimated at 70%.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
116
Inclusion Criteria
  • Patient having given free and informed consent.
  • Patient who has signed the consent form.
  • Patient affiliated to or beneficiary of a health insurance plan.
  • Patient with a BMI < 35 kg/m2
Exclusion Criteria
  • Patient participating in research involving human subjects defined as Category 1.
  • Patient in an exclusion period as determined by another study.
  • Patient under court protection, guardianship or trusteeship.
  • Patient unable to give consent.
  • Patient for whom it is impossible to give informed information.
  • Pregnant patient.
  • Patient with a BMI ≥ 35 kg/m2

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Patients undergoing Ultra-Low-Dose scan plus conventional standard dose thoraco-abdominopelvic scanUltra-Low-Dose thoraco-abdominopelvic scanAll adult patients (except pregnant women) presenting to the imaging department of the Institut de Cancérologie du Gard for a thoraco-abdominopelvic scan as part of an oncology follow-up will under a standard-dose can as well as an ultra-low-dose scan.
Primary Outcome Measures
NameTimeMethod
Concordance of the global quality of thoraco-abdomino-pelvic images from an Ultra-Low-Dose scanner acquisition compared to a standard dose scanner acquisitionDay 0

A 4-point Likert scale will be used to evaluate the overall image quality to see whether it is good enough to visualize the structures of interest and possible lesions.

Overall image quality is rated as follows:

1. Completely interpretable without noise, smoothing, and/or artifact,

2. Completely interpretable with low artifacts and/or low level of noise or/and smoothing,

3. Interpretable with moderate noise and/or smoothing and moderate artifacts,

4. Uninterpretable

Secondary Outcome Measures
NameTimeMethod
Frequency of good quality images with the Ultra-Low-Dose scannerDay 0

Distribution of image quality for each of the two examinations of interest (ULD scanner and standard dose scanner) and to estimate the frequency of good quality images (level 1-2) for each of the two examinations. Grouping of the variable into 2 classes for the estimation of the frequency of good quality (1-2) images:- 1-2 vs. 3-4

Confidence level of each radiologist's diagnosis : Ultra-Low-Dose scan acquisitionDay 0

To compare the confidence level of each radiologist's diagnosis for each of the two examinations of interest (Ultra-Low-Dose scan and standard dose scan) a subjective assessment of the each radiologist's (Junior/Senior) diagnostic confidence level will be made.

Frequency of good quality images with the standard dose scannerDay 0

Distribution of image quality for each of the two examinations of interest (ULD scanner and standard dose scanner) and to estimate the frequency of good quality images (level 1-2) for each of the two examinations. Grouping of the variable into 2 classes for the estimation of the frequency of good quality (1-2) images:- 1-2 vs. 3-4

Distribution of image quality with the standard dose scannerDay 0

Distribution of image quality for each of the two examinations of interest (ULD scanner and standard dose scanner) and to estimate the frequency of good quality images (level 1-2) for each of the two examinations.

1. - Fully interpretable without noise, smoothing and/or artifact,

2. - Fully interpretable with low artifacts and/or low noise and/or smoothing,

3. - Interpretable despite moderate noise and/or smoothing and moderate artifacts,

4. - Not interpretable

Distribution of image quality with the Ultra-Low-Dose scannerDay 0

Distribution of image quality for each of the two examinations of interest (ULD scanner and standard dose scanner) and to estimate the frequency of good quality images (level 1-2) for each of the two examinations.

1. - Fully interpretable without noise, smoothing and/or artifact,

2. - Fully interpretable with low artifacts and/or low noise and/or smoothing,

3. - Interpretable despite moderate noise and/or smoothing and moderate artifacts,

4. - Not interpretable

Overall concordance of the diagnosis. Pelvic bone lesions seen on the Ultra-Low-Dose scanDay 0

Overall concordance of the diagnosis of bone lesions of the spine and pelvis made from a ULD scan or from a standard dose CT scan in these patients. Presence of at least one bone lesion on the pelvis (Yes/No).

Overall concordance of the diagnosis. Pelvic bone lesions seen on the Standard-Dose scanDay 0

Overall concordance of the diagnosis of bone lesions of the spine and pelvis made from a ULD scan or from a standard dose CT scan in these patients. Presence of at least one bone lesion on the pelvis (Yes/No).

Overall concordance of the diagnosis. Thoracic lesions seen on the Ultra-Low-Dose scanDay 0

Overall concordance of the diagnosis of thoracic, abdominal and/or pelvic lesions made from a ULD scan or from a conventional standard dose scan in these patients.

Presence of at least one thoracic, (Yes/No)

Overall concordance of the diagnosis. Pelvic lesions seen on the Ultra-Low-Dose scanDay 0

Overall concordance of the diagnosis of thoracic, abdominal and/or pelvic lesions made from a ULD scan or from a conventional standard dose scan in these patients. Presence of at least one pelvic lesion (Yes/No)

Overall concordance of the diagnosis. Pelvic lesions seen on the Standard-Dose scanDay 0

Overall concordance of the diagnosis of thoracic, abdominal and/or pelvic lesions made from a ULD scan or from a conventional standard dose scan in these patients. Presence of at least one pelvic lesion (Yes/No)

Confidence level of each radiologist's diagnosis : Standard-Dose scan acquisitionDay 0

To compare the confidence level of each radiologist's diagnosis for each of the two examinations of interest (Ultra-Low-Dose scan and standard dose scan) a subjective assessment of the each radiologist's (Junior/Senior) diagnostic confidence level will be made.

Inter-rater agreement (Senior vs. junior radiologist) regarding the Standard-Dose scan acquisitionsDay 0

Likert scales for global image quality and the level of confidence of the diagnosis will be used to assess inter-rater agreement (senior radiologist vs. junior radiologist) for each CT acquisition.

Overall concordance of the diagnosis. Abdominal lesions seen on the Ultra-Low-Dose scanDay 0

Overall concordance of the diagnosis of thoracic, abdominal and/or pelvic lesions made from a ULD scan or from a conventional standard dose scan in these patients. Presence of at least one abdominal lesion (Yes/No)

Overall concordance of the diagnosis. Abdominal lesions seen on the Standard-Dose scanDay 0

Overall concordance of the diagnosis of thoracic, abdominal and/or pelvic lesions made from a ULD scan or from a conventional standard dose scan in these patients. Presence of at least one abdominal lesion (Yes/No)

Inter-rater agreement (Senior vs. junior radiologist) regarding the Ultra-Low-Dose scan acquisitionsDay 0

Likert scales for global image quality and the level of confidence of the diagnosis will be used to assess inter-rater agreement (senior radiologist vs. junior radiologist) for each CT acquisition.

Overall concordance of the diagnosis. Thoracic lesions seen on the Standard-Dose scanDay 0

Overall concordance of the diagnosis of thoracic, abdominal and/or pelvic lesions made from a ULD scan or from a conventional standard dose scan in these patients. Presence of at least one thoracic lesion (Yes/No)

Overall concordance of the diagnosis. Spine lesions seen on the Ultra-Low-Dose scanDay 0

Overall concordance of the diagnosis of bone lesions of the spine and pelvis made from a ULD scan or from a standard dose CT scan in these patients. Presence of at least one bone lesion within the spine (Yes/No).

Overall concordance of the diagnosis. Spine lesions seen on the Standard-Dose scanDay 0

Overall concordance of the diagnosis of bone lesions of the spine and pelvis made from a ULD scan or from a standard dose CT scan in these patients. Presence of at least one bone lesion within the spine (Yes/No).

Trial Locations

Locations (1)

CHU

🇫🇷

Nîmes, France

© Copyright 2025. All Rights Reserved by MedPath